These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21832076)

  • 21. Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells.
    O'Loughlin EV; Robins-Browne RM
    Microbes Infect; 2001 May; 3(6):493-507. PubMed ID: 11377211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
    Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.
    Zumbrun SD; Hanson L; Sinclair JF; Freedy J; Melton-Celsa AR; Rodriguez-Canales J; Hanson JC; O'Brien AD
    Infect Immun; 2010 Nov; 78(11):4488-99. PubMed ID: 20732996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration.
    Hurley BP; Thorpe CM; Acheson DW
    Infect Immun; 2001 Oct; 69(10):6148-55. PubMed ID: 11553554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of Neutrophil Extracellular Traps in Shiga Toxin-Associated Hemolytic Uremic Syndrome.
    Ramos MV; Mejias MP; Sabbione F; Fernandez-Brando RJ; Santiago AP; Amaral MM; Exeni R; Trevani AS; Palermo MS
    J Innate Immun; 2016; 8(4):400-11. PubMed ID: 27230920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers.
    Nolasco LH; Turner NA; Bernardo A; Tao Z; Cleary TG; Dong JF; Moake JL
    Blood; 2005 Dec; 106(13):4199-209. PubMed ID: 16131569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial heterogeneity in Shiga toxin receptors and responses.
    Obrig TG; Louise CB; Lingwood CA; Boyd B; Barley-Maloney L; Daniel TO
    J Biol Chem; 1993 Jul; 268(21):15484-8. PubMed ID: 8340376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome.
    Nestoridi E; Tsukurov O; Kushak RI; Ingelfinger JR; Grabowski EF
    J Thromb Haemost; 2005 Apr; 3(4):752-62. PubMed ID: 15842359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome.
    Karpman D; Papadopoulou D; Nilsson K; Sjögren AC; Mikaelsson C; Lethagen S
    Blood; 2001 May; 97(10):3100-8. PubMed ID: 11342436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shiga toxins: from structure and mechanism to applications.
    Chan YS; Ng TB
    Appl Microbiol Biotechnol; 2016 Feb; 100(4):1597-1610. PubMed ID: 26685676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice.
    Petruzziello-Pellegrini TN; Yuen DA; Page AV; Patel S; Soltyk AM; Matouk CC; Wong DK; Turgeon PJ; Fish JE; Ho JJ; Steer BM; Khajoee V; Tigdi J; Lee WL; Motto DG; Advani A; Gilbert RE; Karumanchi SA; Robinson LA; Tarr PI; Liles WC; Brunton JL; Marsden PA
    J Clin Invest; 2012 Feb; 122(2):759-76. PubMed ID: 22232208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
    Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.
    Bielaszewska M; Friedrich AW; Aldick T; Schürk-Bulgrin R; Karch H
    Clin Infect Dis; 2006 Nov; 43(9):1160-7. PubMed ID: 17029135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil Extracellular Traps Induced by Shiga Toxin and Lipopolysaccharide-Treated Platelets Exacerbate Endothelial Cell Damage.
    Landoni VI; Pittaluga JR; Carestia A; Castillo LA; Nebel MC; Martire-Greco D; Birnberg-Weiss F; Schattner M; Schierloh P; Fernández GC
    Front Cell Infect Microbiol; 2022; 12():897019. PubMed ID: 35811684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Biology of
    Menge C
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32456125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AB5 Preassembly Is Not Required for Shiga Toxin Activity.
    Pellino CA; Karve SS; Pradhan S; Weiss AA
    J Bacteriol; 2016 Jun; 198(11):1621-1630. PubMed ID: 27002129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rapid and sensitive method to measure the functional activity of Shiga toxins in human serum.
    Arfilli V; Carnicelli D; Ardissino G; Torresani E; Scavia G; Brigotti M
    Toxins (Basel); 2015 Nov; 7(11):4564-76. PubMed ID: 26556372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals.
    Mainil J
    Vet Res; 1999; 30(2-3):235-57. PubMed ID: 10367357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome.
    Tazzari PL; Ricci F; Carnicelli D; Caprioli A; Tozzi AE; Rizzoni G; Conte R; Brigotti M
    Cytometry B Clin Cytom; 2004 Sep; 61(1):40-4. PubMed ID: 15351981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shiga Toxin (Stx)-Binding Glycosphingolipids of Primary Human Renal Cortical Epithelial Cells (pHRCEpiCs) and Stx-Mediated Cytotoxicity.
    Detzner J; Krojnewski E; Pohlentz G; Steil D; Humpf HU; Mellmann A; Karch H; Müthing J
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33673393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.